Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-tumor adjacent tissue of advanced stage from CRC shows activated antioxidant response.
Hernández-López R, Torrens-Mas M, Pons DG, Company MM, Falcó E, Fernández T, Ibarra de la Rosa JM, Sastre-Serra J, Oliver J, Roca P. Hernández-López R, et al. Among authors: falco e. Free Radic Biol Med. 2018 Oct;126:249-258. doi: 10.1016/j.freeradbiomed.2018.08.021. Epub 2018 Aug 18. Free Radic Biol Med. 2018. PMID: 30130568
Antioxidant enzymes change in different non-metastatic stages in tumoral and peritumoral tissues of colorectal cancer.
Gaya-Bover A, Hernández-López R, Alorda-Clara M, Ibarra de la Rosa JM, Falcó E, Fernández T, Company MM, Torrens-Mas M, Roca P, Oliver J, Sastre-Serra J, Pons DG. Gaya-Bover A, et al. Among authors: falco e. Int J Biochem Cell Biol. 2020 Mar;120:105698. doi: 10.1016/j.biocel.2020.105698. Epub 2020 Jan 22. Int J Biochem Cell Biol. 2020. PMID: 31981728
Inflammation- and Metastasis-Related Proteins Expression Changes in Early Stages in Tumor and Non-Tumor Adjacent Tissues of Colorectal Cancer Samples.
Alorda-Clara M, Torrens-Mas M, Hernández-López R, Ibarra de la Rosa JM, Falcó E, Fernández T, Company MM, Sastre-Serra J, Oliver J, Pons DG, Roca P. Alorda-Clara M, et al. Among authors: falco e. Cancers (Basel). 2022 Sep 16;14(18):4487. doi: 10.3390/cancers14184487. Cancers (Basel). 2022. PMID: 36139645 Free PMC article.
Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease.
Aparicio J, Esposito F, Serrano S, Falco E, Escudero P, Ruiz-Casado A, Manzano H, Fernandez-Montes A. Aparicio J, et al. Among authors: falco e. J Clin Med. 2020 Nov 30;9(12):3889. doi: 10.3390/jcm9123889. J Clin Med. 2020. PMID: 33265959 Free PMC article. Review.
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer.
Fernández Montes A, Alonso Orduña V, Asensio Martínez E, Rodríguez Salas N, Torres E, Cacho Lavín D, Rodríguez Alonso RM, Falcó E, Oliva JC, Cirera L, García Gómez J, Pericay C. Fernández Montes A, et al. Among authors: falco e. Oncologist. 2023 Oct 3;28(10):e902-e909. doi: 10.1093/oncolo/oyad117. Oncologist. 2023. PMID: 37141400 Free PMC article.
Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study.
Pericay C, Fernández Montes A, Alonso Orduña V, Macias Declara I, Asensio Martínez E, Rodríguez Salas N, Torres E, Cacho Lavín D, Rodríguez Alonso RM, Falcó E, Oliva JC, Cirera L. Pericay C, et al. Among authors: falco e. Cancers (Basel). 2023 Sep 17;15(18):4603. doi: 10.3390/cancers15184603. Cancers (Basel). 2023. PMID: 37760572 Free PMC article.
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.
Irigoyen A, Gallego J, Guillén Ponce C, Vera R, Iranzo V, Ales I, Arévalo S, Pisa A, Martín M, Salud A, Falcó E, Sáenz A, Manzano Mozo JL, Pulido G, Martínez Galán J, Pazo-Cid R, Rivera F, García García T, Serra O, Fernández Parra EM, Hurtado A, Gómez Reina MJ, López Gomez LJ, Martínez Ortega E, Benavides M, Aranda E; Spanish Cooperative Group of Treatment of Digestive Tumors (TTD). Irigoyen A, et al. Among authors: falco e. Eur J Cancer. 2017 Apr;75:73-82. doi: 10.1016/j.ejca.2016.12.032. Epub 2017 Mar 7. Eur J Cancer. 2017. PMID: 28222309 Clinical Trial.
Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.
Gómez-Martin C, Sánchez A, Irigoyen A, Llorente B, Pérez B, Serrano R, Safont MJ, Falcó E, Lacasta A, Reboredo M, Aparicio J, Dueñas R, Muñoz ML, Regueiro P, Sanchez-Viñes E, López RL. Gómez-Martin C, et al. Among authors: falco e. Clin Transl Oncol. 2012 Sep;14(9):689-97. doi: 10.1007/s12094-012-0858-3. Epub 2012 Jul 19. Clin Transl Oncol. 2012. PMID: 22855151 Clinical Trial.
264 results